Literature DB >> 12033640

Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions.

E Bard1, D Riethmuller, S Biichlé, D Meillet, J L Prétet, C Mougin, E Seillès.   

Abstract

Several studies were carried out to characterize the humoral immune response on mucosal genital surfaces. However, the results obtained so far were particularly conflicting due to the absence of validation methods. The aim of this study was to develop and validate a quantitative ELISA method, which is sensitive and reproducible, to measure immunoglobulin and secretory immunoglobulin concentrations in various biological fluids. This quantitative, sensitive (detection limit = 1 microg/L) and reproducible (coefficient of variation < 15%) method could be of interest to study the effects of viral infections on mucosal non-specific immune response in genital tract. To explore the humoral response, serum, saliva, vaginal secretions, and cervicovaginal secretions from 18 women, 20-45 years old, were evaluated for total-IgA, secretory IgA, IgM, and IgG. Albumin level was also evaluated by immuno-nephelometry. The secretion rates of immunoglobulins were measured by calculating their relative coefficients of excretion by reference to albumin. Despite large individual variations, median immunoglobulin levels were higher in the endocervical secretions than in the cervicovaginal secretions. When we compared the rates of immunoglobulins in genital fluids, IgG prevalence was higher (80%) in cervicovaginal and endocervical secretions than IgA prevalence (12%). In contrast, digestive mucosal secretions, such as saliva, contained mostly IgA (80%). In cervicovaginal and endocervical secretions, IgG and IgM originated mainly from serum, whereas a local synthesis provided total-IgA and secretory IgA. These results allowed us to raise a possible hypothesis for the origin of immunoglobulins in the genital tract. They illustrated the peculiar feature of the female reproductive tract and the difficulty for this tissue to contribute in the mucosal associated lymphoid tissue. The low secretory-IgA and total-IgA levels could explain the particular sensitivity of the vagina and the cervix to infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033640     DOI: 10.1081/IAS-120003658

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  7 in total

1.  Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.

Authors:  Rhoda Sperling; Thomas A Kraus; Jian Ding; Alina Veretennikova; Elizabeth Lorde-Rollins; Tricia Singh; Yungtai Lo; Alison J Quayle; Theresa L Chang
Journal:  J Reprod Immunol       Date:  2013-08-08       Impact factor: 4.054

2.  Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.

Authors:  Jobin Eslahpazir; Mohammad-Ali Jenabian; Hicham Bouhlal; Hakim Hocini; Cédric Carbonneil; Gérard Grésenguet; François-Xavier Mbopi Kéou; Jérôme LeGoff; Héla Saïdi; Mary Requena; Nadine Nasreddine; Jean de Dieu Longo; Srinivas V Kaveri; Laurent Bélec
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

Review 3.  Vaginal microbiota in pregnancy: Role in induction of labor and seeding the neonate''s microbiota?

Authors:  Kaisa Kervinen; Ilkka Kalliala; Sivan Glazer-Livson; Seppo Virtanen; Pekka Nieminen; Anne Salonen
Journal:  J Biosci       Date:  2019-10       Impact factor: 1.826

4.  Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women.

Authors:  Nonhlanhla N Mkhize; Raveshni Durgiah; Vicki Ashley; Derseree Archary; Nigel J Garrett; Quarraisha Abdool Karim; Salim S Abdool Karim; Penny L Moore; Nicole Yates; Jo-Ann S Passmore; Georgia D Tomaras; Lynn Morris
Journal:  AIDS       Date:  2016-04-24       Impact factor: 4.177

5.  Activation of the Complement System in the Lower Genital Tract During Pregnancy and Delivery.

Authors:  Sivan Livson; Hanna Jarva; Ilkka Kalliala; A Inkeri Lokki; Jenni Heikkinen-Eloranta; Pekka Nieminen; Seppo Meri
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

6.  Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition.

Authors:  Sivan Livson; Seppo Virtanen; A Inkeri Lokki; Tiina Holster; Leena Rahkonen; Ilkka Kalliala; Pekka Nieminen; Anne Salonen; Seppo Meri
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

7.  Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.

Authors:  D Archary; K E Seaton; J S Passmore; L Werner; A Deal; L J Dunphy; K B Arnold; N L Yates; D A Lauffenburger; P Bergin; L J Liebenberg; N Samsunder; M W Mureithi; M Altfeld; N Garrett; Q Abdool Karim; Ss Abdool Karim; L Morris; G D Tomaras
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.